U.S. Food & Drug Administration · August 24, 2026
Vitruvias Therapeutics Thyroid Tablets, USP 30 mg Recall: Potential for the Product to be Superpotent
- Affected product
- Vitruvias Therapeutics Thyroid Tablets, USP 30 mg
- Category
- Drugs
- Hazard
- Potential for the Product to be Superpotent